[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1113987T1 - MODIFIED nucleosides for the treatment of viral infections and abnormal cell proliferation - Google Patents

MODIFIED nucleosides for the treatment of viral infections and abnormal cell proliferation

Info

Publication number
CY1113987T1
CY1113987T1 CY20131100383T CY131100383T CY1113987T1 CY 1113987 T1 CY1113987 T1 CY 1113987T1 CY 20131100383 T CY20131100383 T CY 20131100383T CY 131100383 T CY131100383 T CY 131100383T CY 1113987 T1 CY1113987 T1 CY 1113987T1
Authority
CY
Cyprus
Prior art keywords
treatment
cell proliferation
viral infections
abnormal cell
modified nucleosides
Prior art date
Application number
CY20131100383T
Other languages
Greek (el)
Inventor
Lieven Stuyver
Kyoichi A Watanabe
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10175643A external-priority patent/EP2251015B1/en
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Publication of CY1113987T1 publication Critical patent/CY1113987T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Η εφεύρεση που κοινοποιείται είναι μια σύνθεση για τη θεραπεία και μια μέθοδος θεραπείας μιας μόλυνσης Flaviviridae [συμπεριλαμβανομένου του Ιού της Ιογενούς Διάρροιας των Βοοειδών (BVDV) και της Ηπατίτιδας C (HCV)] σε ένα ξενιστή, όπου περιλαμβάνονται ζώα και ιδιαίτερα οι άνθρωποι, χρησιμοποιώντας ένα νουκλεοσίδιο του γενικού τύπου (I-b) ή το φαρμακευτικώς αποδεκτό άλας αυτού.The invention disclosed is a composition for the treatment and method of treatment of a Flaviviridae infection (including Bovine Viral Diarrhea Virus (BVDV) and Hepatitis C (HCV)) in a host, including animals and particularly humans, using a nucleoside of general formula (Ib) or a pharmaceutically acceptable salt thereof.

CY20131100383T 2000-10-18 2013-05-13 MODIFIED nucleosides for the treatment of viral infections and abnormal cell proliferation CY1113987T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24148800A 2000-10-18 2000-10-18
US28215601A 2001-04-06 2001-04-06
EP10175643A EP2251015B1 (en) 2000-10-18 2001-10-18 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation

Publications (1)

Publication Number Publication Date
CY1113987T1 true CY1113987T1 (en) 2016-07-27

Family

ID=58448988

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100383T CY1113987T1 (en) 2000-10-18 2013-05-13 MODIFIED nucleosides for the treatment of viral infections and abnormal cell proliferation

Country Status (1)

Country Link
CY (1) CY1113987T1 (en)

Similar Documents

Publication Publication Date Title
DK2251015T3 (en) Modified nucleotides to treat viral infections and abnormal cell proliferation
NO20051969L (en) Nucleoside derivatives for the treatment of hepatitis C virus infection.
CY1109012T1 (en) NUCLEOSIDE DERIVATIVES AS RNA-dependent INFLAMMATORS OF RNA IMPLANT
AR114929A2 (en) MODIFIED FLUORINE NUCLEOSID ANALOGUES
WO2003093290A8 (en) Nucleoside derivatives for treating hepatitis c virus infection
DK1569929T3 (en) Compounds and Methods for Treating or Preventing Flavivirus Infections
EA200000840A1 (en) ANTI-VIRUS DERIVATIVES OF PYRIMIDINE
NO20073151L (en) Methods and compositions for treating hepatitis C virus
NO20070194L (en) Methods for the treatment of hepatitis C
ATE420078T1 (en) PYRIMIDINONES AS VIRAL POLYMERASE INHIBITORS
BR0305259A (en) Hcv ns5b polymerase inhibitors
DOP2003000641A (en) INHIBITORS OF RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUSES AND COMPOSITIONS AND TREATMENT USED
WO2004084796A3 (en) Compounds for the treatment of flaviviridae infections
CA2480583A1 (en) Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
CY1113987T1 (en) MODIFIED nucleosides for the treatment of viral infections and abnormal cell proliferation